About Intellect Life Science
Intellect Life Science is a Healthcare company. Pharmaceutical manufacturing and distribution focusing on healthcare products in India. The company has 10 employees. Its Indian entity Intellect Life Sciences Private Limited reported revenue of ₹6.55 Cr. Intellect Life Science offers products and services including Cefoveed 200 Tablets and TrumpClav Dry Syrup. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Life Sciences.
Company details
Intellect Life Science is identified as a pharmaceutical company that seeks to provide employment opportunities and emerge as a key global player. It is noted for its commitment to delivering high-quality products and services, with core values centered on being people-driven and customer-oriented. Various pharmaceutical items, including tablets and syrups, are offered to support healthcare needs. The organization is recognized for upholding integrity and striving for excellence in quality, while offices are established in Pune and Nasik, India, to facilitate operations.
- Employees 10
- SectorsHealthcare
- Legal Name Intellect Life Sciences Pvt. Ltd
- Date of Incorporation 11 Apr, 2012
- Jurisdiction Nashik, Maharashtra, India
- Indian entity revenue₹6.55 Cr
FY 2025 · +27% YoY
- Indian entity net profit₹57.3 Lakh
FY 2025 · 9% margin
- Indian entity EBITDA₹1.13 Cr
FY 2025 · 17% margin
- Employee Count10
Associated legal entities of Intellect Life Science
Intellect Life Science operates through Intellect Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Intellect Life Sciences Private Limited CIN U24233MH2012PTC229492 | Active | 11 Apr 2012 | Nashik, Maharashtra | ₹6.6 Cr | 10 | 4 | View details |
Products & Services of Intellect Life Science
Intellect Life Science offers a comprehensive portfolio of products and services, including Cefoveed 200 Tablets and TrumpClav Dry Syrup.
Tablets are manufactured for medical applications in healthcare settings
Dry syrup is produced for pharmaceutical use in treatment purposes
Board of directors of Intellect Life Sciences Private Limited (Intellect Life Science)
Intellect Life Sciences Private Limited is the primary company behind Intellect Life Science. The board of Intellect Life Sciences Private Limited currently have 4 directors; the longest-serving is Hemant Murlidhar Pachpute, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemant Murlidhar Pachpute DIN 05228202 | Director | 11 Apr 2012 | 14 yrs 6 mo | Intellect Life Sciences Private Limited |
| Muralidhar Mahadu Wani DIN 05205785 | Director | 11 Apr 2012 | 14 yrs 6 mo | Intellect Life Sciences Private Limited |
| Rohini Hemant Pachpute DIN 05205784 | Director | 11 Apr 2012 | 14 yrs 6 mo | Intellect Life Sciences Private Limited |
| Kaushalyabai Murlidhar Wani DIN 06400247 | Director | 01 Oct 2012 | 14 yrs | Intellect Life Sciences Private Limited |
Financials of Intellect Life Science
Figures of Intellect Life Sciences Private Limited, the primary company behind Intellect Life Science, for FY 2025. Revenue was ₹6.55 Cr (+27% year on year). Net profit was ₹57.3 Lakh (9% margin). EBITDA was ₹1.13 Cr (17% margin). Revenue has grown at a compounded annual rate of +10% over three years and +4% over five years.
- ₹6.55 CrRevenue · FY 2025 · +27% YoY
- ₹57.3 LakhNet profit · 9% margin
- ₹1.13 CrEBITDA · 17% margin
- ₹1.00 CrPaid-up capital
- 10Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Intellect Life Sciences Private Limited are on its company page.
Detailed financial statements for Intellect Life Science
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Intellect Life Science
Intellect Life Science has 10 employees.
The primary company behind Intellect Life Science, Intellect Life Sciences Private Limited, reported revenue of ₹6.55 Cr for FY 2025, up 27% year on year.
Intellect Life Science is identified as a pharmaceutical company that seeks to provide employment opportunities and emerge as a key global player. It is noted for its commitment to delivering high-quality products and services, with core values centered on being people-driven and customer-oriented. Various pharmaceutical items, including tablets and syrups, are offered to support healthcare needs. The organization is recognized for upholding integrity and striving for excellence in quality, while offices are established in Pune and Nasik, India, to facilitate operations.
Intellect Life Science offers Cefoveed 200 Tablets and TrumpClav Dry Syrup.
Intellect Life Science operates through Intellect Life Sciences Private Limited.
The legal entities of Intellect Life Science currently have 4 directors, including Hemant Murlidhar Pachpute, Muralidhar Mahadu Wani, Rohini Hemant Pachpute and others.